Omega 3

Verify with FDA CVM →

36 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
36
Total Reports
3
Deaths Reported
830.0%
Death Rate

Active Ingredients

Omega 3

Administration Routes

OralUnknown

Species Affected

Dog 35
Cat 1

Most Affected Breeds

Retriever - Golden 5
Retriever - Labrador 4
Terrier - Yorkshire 3
Dog (unknown) 2
Schnauzer - Miniature 2
Pointing Dog - Hungarian Short-haired (Vizsla) 2
Pit Bull 2
Bulldog - English 2
Shepherd Dog - Australian 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1

Most Reported Reactions

Vomiting 6
Weight loss 4
Lethargy (see also Central nervous system depression in 'Neurological') 4
Other abnormal test result NOS 4
Elevated total bilirubin 4
Underdose 4
Urinary tract infection 4
Not eating 3
Elevated blood urea nitrogen (BUN) 3
Elevated creatinine 3
Elevated cholesterol (total) 3
Elevated alanine aminotransferase (ALT) 3

Outcome Breakdown

Outcome Unknown
14 (38.9%)
Recovered/Normal
9 (25.0%)
Ongoing
8 (22.2%)
Recovered with Sequela
2 (5.6%)
Euthanized
2 (5.6%)
Died
1 (2.8%)

Data Summary

Metric Value
Total adverse event reports 36
Reports involving death 3
Case-fatality rate (reported events) 830.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Omega 3 Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 36 adverse event reports referencing Omega 3, including 3 reports in which the animal died — a 830.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Omega 3. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Omega 3 reports are Dog (35 reports), Cat (1 reports), with Dog accounting for the largest share. Within those species, Retriever - Golden (5), Retriever - Labrador (4), Terrier - Yorkshire (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Omega 3 are Vomiting (6), Weight loss (4), Lethargy (see also Central nervous system depression in 'Neurological') (4), Other abnormal test result NOS (4). Of the 36 reports with a coded outcome, Outcome Unknown is the leading category at 38.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Omega 3.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial